December 20, 2016

AstraZeneca has parted company with its head of oncology, who is returning to his native France to take up the post of chief executive of the biotechnology company Innate Pharma. The pharmaceuticals group said that it already had a replacement for Mondher Mahjoubi.

Read the full article on TheTimes.uk